Inflammatory cytokines such as IFN-γ, TNF-α, and IL-1 are markedly increased in patients affected by acute GVHD, which potentially explains why clinical efficacy has been more conclusively demonstrated when there are mores severe manifestations of acute GVHD [55,56]. The gene discussed is IL1B; the disease is acute graft versus host disease.